PAMU
SRNE

Pictet Asset Management (UK)’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Pictet Asset Management (UK)’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$185K Sell
19,066
-2,934
-13% -$23.4K ﹤0.01% 1653
2021
Q1 		$182K Sell
22,000
-2,700
-11% -$28.5K ﹤0.01% 1699
2020
Q4 		$169K Buy
24,700
+13,800
+127% +$111K ﹤0.01% 1639
2020
Q3 		$122K Buy
+10,900
New +$99.8K ﹤0.01% 1473

Other funds holding SRNE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Pictet Asset Management (UK)'s SRNE Position: Q2 2021 in Review

Pictet Asset Management (UK) reduced its Sorrento Therapeutics, Inc. (SRNE) stake by 13% in Q2 2021, selling an estimated $23.4K and leaving 19,066 shares worth $185K. The position accounts for ﹤0.01% of the portfolio, ranked #1653.

Pictet Asset Management (UK) first reported a position in SRNE in Q3 2020 and has held it in 4 quarters since. 212 funds tracked by Wall St. Rank hold SRNE as of Q2 2021.

  • Pictet Asset Management (UK) held 19,066 shares of Sorrento Therapeutics, Inc. worth $185K as of Q2 2021.
  • Pictet Asset Management (UK) sold 2,934 Sorrento Therapeutics, Inc. shares in Q2 2021, an estimated $23.4K.
  • Sorrento Therapeutics, Inc. made up ﹤0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #1653 holding.
  • Pictet Asset Management (UK) first reported a position in Sorrento Therapeutics, Inc. in Q3 2020 and has held it in 4 quarters since.
  • 212 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.